Fa-da Wang

Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

The interprofessional nurse-physician model in comprehensive management of chronic hepatitis B: An updated review.

The interprofessional nurse-physician model in comprehensive management of chronic hepatitis B: An updated review.

Journal: Journal of virus eradication

Published: February 09, 2025

Mesenchymal Stem Cell-derived Exosomes in the Treatment of End-stage Liver Disease.

Mesenchymal Stem Cell-derived Exosomes in the Treatment of End-stage Liver Disease.

Journal: Current stem cell research & therapy

Published: December 04, 2024

Nucleos(t)ide analogs to treat patients with positive hepatitis B virus deoxyribonucleic acid and normal alanine transaminase: protocol for an open-label single-center randomized parallel controlled trial.

Nucleos(t)ide analogs to treat patients with positive hepatitis B virus deoxyribonucleic acid and normal alanine transaminase: protocol for an open-label single-center randomized parallel controlled trial.

Journal: Trials

Published: October 30, 2023

Antiviral Therapy Favors a Lower Risk of Liver Cirrhosis in HBeAg-negative Chronic Hepatitis B with Normal Alanine Transaminase and HBV DNA Positivity.

Antiviral Therapy Favors a Lower Risk of Liver Cirrhosis in HBeAg-negative Chronic Hepatitis B with Normal Alanine Transaminase and HBV DNA Positivity.

Journal: Journal of clinical and translational hepatology

Published: June 06, 2023

Letter: serum HBV RNA and HBcrAg may help to evaluate safely stopping nucleot(s)ide analogues in patients with HBeAg-negative chronic hepatitis B and without cirrhosis.

Letter: serum HBV RNA and HBcrAg may help to evaluate safely stopping nucleot(s)ide analogues in patients with HBeAg-negative chronic hepatitis B and without cirrhosis.

Journal: Alimentary pharmacology & therapeutics

Published: September 07, 2022

Management of in- and out-of-hospital screening for hepatitis C.

Management of in- and out-of-hospital screening for hepatitis C.

Journal: Frontiers in public health

Published: July 02, 2022

Serum Pregenomic RNA Combined With Hepatitis B Core-Related Antigen Helps Predict the Risk of Virological Relapse After Discontinuation of Nucleos(t)ide Analogs in Patients With Chronic Hepatitis B.

Serum Pregenomic RNA Combined With Hepatitis B Core-Related Antigen Helps Predict the Risk of Virological Relapse After Discontinuation of Nucleos(t)ide Analogs in Patients With Chronic Hepatitis B.

Journal: Frontiers in microbiology

Published: March 21, 2022

Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis.

Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis.

Journal: Frontiers in pharmacology

Published: October 01, 2021

Retrospective Analysis of the Clinical Efficacy of N-Acetylcysteine in the Treatment of Hepatitis B Virus Related Acute-on-Chronic Liver Failure.

Retrospective Analysis of the Clinical Efficacy of N-Acetylcysteine in the Treatment of Hepatitis B Virus Related Acute-on-Chronic Liver Failure.

Journal: Frontiers in medicine

Published: June 12, 2021

Antiviral Therapy for Chronic HBV Infection With Persistently Normal Alanine Aminotransferase: Controversy and Consensus.

Antiviral Therapy for Chronic HBV Infection With Persistently Normal Alanine Aminotransferase: Controversy and Consensus.

Journal: Frontiers in medicine

Published: May 30, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026